Höffken K, Steih U, Schmidt C G
J Cancer Res Clin Oncol. 1982;104(3):237-47. doi: 10.1007/BF00406244.
Inbred mice were immunized with various cellular and subcellular preparations from a syngeneic, methylcholanthrene-induced sarcoma to induce transplantation immunity against a subsequent challenge of viable cells from the same tumor. Only with conventional immunization procedures using radiation-attenuated tumor cells or viable tumor cells in admixture with bacillus Calmette-Guérin was transplantation immunity obtained. Neither native soluble tumor extracts prepared using several extraction methods, nor cross-linked preparations of these extracts gave rise to transplantation immunity. With few exceptions, however, the immunizing preparations resulted in the production of tumor-specific humoral antibody. The manner in which tumor antigens are presented to the host as well as the experimental system (animal strain; tumor) used appear to play an important role in the development of transplantation immunity against tumors.
用同基因的、甲基胆蒽诱导的肉瘤的各种细胞和亚细胞制剂对近交系小鼠进行免疫,以诱导针对随后来自同一肿瘤的活细胞攻击的移植免疫。只有使用经辐射减毒的肿瘤细胞或与卡介苗混合的活肿瘤细胞的传统免疫程序才能获得移植免疫。使用几种提取方法制备的天然可溶性肿瘤提取物,以及这些提取物的交联制剂均未产生移植免疫。然而,除了少数例外,免疫制剂导致了肿瘤特异性体液抗体的产生。肿瘤抗原呈递给宿主的方式以及所使用的实验系统(动物品系;肿瘤)似乎在针对肿瘤的移植免疫的发展中起重要作用。